M Ventures

Corporate venture capital

RollingLast verified 7 Nov 2026

Amsterdam-based corporate-backed venture capital fund investing in Seed and Series A startups across biotech, life sciences tools, healthcare, and enabling technologies.

3 deals in the last 24 months, latest 5 Nov 2026. From its website and its deals in the news.

Key facts

Stages: Seed, Series A, Series B, Series C+
Sectors: Biotech & pharma, Healthtech, AI & machine learning
Ticket: €445.5K–€2.7M
Typical round size: €100M (median of its recent deals, not a ticket)
Leads rounds: 33% of recent deals with a known role
Eligible countries: Not stated
Provider based in: Netherlands
Timing: Rolling applications
Focus: biotech; life sciences tools; enabling technologies; healthcare; AI / ML
How to apply: Warm introduction only
Source: https://investormatch.pro/vcs/m-ventures

Recent deals

Deals in the last 24 months
Company	Round	Sectors	Amount	Role	Announced
T-Therapeutics	Series B	Biotech & pharma, Healthtech	€118.5M	participant	5 Nov 2026
Cyllene Therapeutics	Series C+	Biotech & pharma	€33M	lead	8 Jul 2026
FMC	Series C+	Semiconductors	€100M	participant	13 Nov 2025

Evidence

Short excerpts from the sources, in their original language, that back the facts above.

KindCorporate-backed specialist fund investing in biotech, life sciences tools, and enabling technologieshttps://investormatch.pro/vcs/m-ventures
Sectorsinvesting in biotech, life sciences tools, and enabling technologieshttps://investormatch.pro/vcs/m-ventures
StagesThe firm invests at the Seed, Series A stageshttps://investormatch.pro/vcs/m-ventures
TicketM Ventures typically writes checks of $500K–$3.0M per investment.https://investormatch.pro/vcs/m-ventures
TicketM Ventures typically writes checks of $500K–$3.0M per investment.https://investormatch.pro/vcs/m-ventures

Status history

6 Nov 2026: Rolling (first extraction)

Something wrong or out of date? Report an error.

Work at M Ventures? Claim this profile to confirm what you invest in.